During the recent session, Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares were 1.03 million, with the beta value of the company hitting 2.02. The 52-week high for the PTPI share is $1.67, that puts it down -1755.56 from that peak though still a striking 22.22% gain since the share price plummeted to a 52-week low of $0.07. The company’s market capitalization is $2.26M, and the average trade volume was 6.40 million shares over the past three months.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Petros Pharmaceuticals Inc (PTPI) registered a -0.22% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.22% in intraday trading to $0.09, hitting a weekly high. The stock’s 5-day price performance is -12.65%, and it has moved by -66.74% in 30 days. Based on these gigs, the overall price performance for the year is -94.49%.

PTPI Dividends

Petros Pharmaceuticals Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Also, the Mutual Funds coming in first place with the largest holdings of Petros Pharmaceuticals Inc (PTPI) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Dec 31, 2024 indicates that Fidelity Extended Market Index Fund owns about 35.02 shares. This amounts to just over 0.31 percent of the company’s overall shares, with a $3099.0 market value. The same data shows that the other fund manager holds slightly less at 31.81, or about 0.28% of the stock, which is worth about $2815.0.